Validation of Joint-AI in Diagnosing Pancreatic Solid Lesions
Condition(s) studied
Investigational drug(s) / intervention(s)
The assistance of the Joint-AI model: Predictions given by the Joint-AI model will be provided to the endoscopists during their diagnosis
The assistance of the interpretable Joint-AI model: Predictions given by the Joint-AI model and the results of the interpretability analysis will be provided to the endoscopists during their diagnosis
Study summary
This clinical trial aims to learn if a multimodal artificial intelligence (AI) model can enhance the diagnosis of pancreatic solid lesions. The main questions it aims to answer are:
1. Does the AI model enhance the diagnostic performance of endoscopists in diagnosing pancreatic solid lesions?
2. Does the addition of interpretability analysis further improve the diagnostic performance of the assisted endoscopists? Researchers will compare the diagnostic performance of endoscopists with or without the assistance of the AI model.
Participants will:
1. Their clinical data will be prospectively collected.
2. They will be randomized to the AI-assist group and the conventional diagnosis group.
Eligibility
Primary outcome measure(s)
- Rate of correct diagnostic classification with assistance of the Joint-AI Model — Through study completion, an average of 1 year
The rate of correct diagnoses in discriminating pancreatic cancer from other non-cancer lesions, determined by comparing endoscopist diagnosis assisted by the Joint-AI model against the final histopathological diagnosis (reference standard). - Rate of correct diagnostic classification with assistance of the Interpretable Joint-AI Model — Through study completion, an average of 1 year
The rate of correct diagnoses in discriminating pancreatic cancer from other non-cancer lesions, determined by comparing endoscopist assessments assisted by the Interpretable Joint-AI model against the final histopathological diagnosis (reference standard)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | Hubei |
More Huazhong University of Science and Technology trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06753318 on ClinicalTrials.gov ↗ ← All trials in China